Pomanda estimates the enterprise value of PRESTIGE DIAGNOSTICS U.K. LTD at £1.8m based on a Turnover of £3.9m and 0.47x industry multiple (adjusted for size and gross margin).
prestige diagnostics u.k. ltdEstimated Valuation
£5.5m
Pomanda estimates the enterprise value of PRESTIGE DIAGNOSTICS U.K. LTD at £5.5m based on an EBITDA of £1.1m and a 4.9x industry multiple (adjusted for size and gross margin).
prestige diagnostics u.k. ltdEstimated Valuation
£4.8m
Pomanda estimates the enterprise value of PRESTIGE DIAGNOSTICS U.K. LTD at £4.8m based on Net Assets of £2.3m and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Prestige Diagnostics U.k. LtdOverview
Prestige Diagnostics U.k. Ltd is a live company located in ballymena, BT42 1HW with a Companies House number of NI610548. It operates in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in January 2012, it's largest shareholder is
siomac ltd
with a 100% stake. Prestige Diagnostics U.k. Ltd is a established,
small sized company, Pomanda has estimated its turnover at
£3.9m with
rapid
growth in recent years.
Pomanda's financial health check has awarded Prestige Diagnostics U.K. Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
Health Rating5out of 5
7 Strong
3 Regular
2 Weak
Size
annual sales of £3.9m, make it smaller than the average company (£12.7m)
£3.9m - Prestige Diagnostics U.k. Ltd
£12.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 159%, show it is growing at a faster rate (6.9%)
159% - Prestige Diagnostics U.k. Ltd
6.9% - Industry AVG
Production
with a gross margin of 39.9%, this company has a comparable cost of product (39.9%)
39.9% - Prestige Diagnostics U.k. Ltd
39.9% - Industry AVG
Profitability
an operating margin of 27.4% make it more profitable than the average company (5.3%)
27.4% - Prestige Diagnostics U.k. Ltd
5.3% - Industry AVG
Employees
with 9 employees, this is below the industry average (42)
9 - Prestige Diagnostics U.k. Ltd
42 - Industry AVG
Pay Structure
on an average salary of £59k, the company has an equivalent pay structure (£59k)
£59k - Prestige Diagnostics U.k. Ltd
£59k - Industry AVG
Efficiency
resulting in sales per employee of £432.4k, this is more efficient (£297.3k)
£432.4k - Prestige Diagnostics U.k. Ltd
£297.3k - Industry AVG
Debtor Days
it gets paid by customers after 9 days, this is earlier than average (48 days)
9 days - Prestige Diagnostics U.k. Ltd
48 days - Industry AVG
Creditor Days
its suppliers are paid after 281 days, this is slower than average (29 days)
281 days - Prestige Diagnostics U.k. Ltd
29 days - Industry AVG
Stock Days
it holds stock equivalent to 4 days, this is less than average (64 days)
4 days - Prestige Diagnostics U.k. Ltd
64 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 58 weeks, this is more cash available to meet short term requirements (15 weeks)
58 weeks - Prestige Diagnostics U.k. Ltd
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 50.1%, this is a similar level of debt than the average (47.5%)
50.1% - Prestige Diagnostics U.k. Ltd
47.5% - Industry AVG
PRESTIGE DIAGNOSTICS U.K. LTD financials
EXPORT
Prestige Diagnostics U.K. Ltd's latest turnover from July 2023 is estimated at £3.9 million and the company has net assets of £2.3 million. According to their latest financial statements, Prestige Diagnostics U.K. Ltd has 9 employees and maintains cash reserves of £2.4 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jul 2023
Jul 2022
Jul 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Turnover
3,892,010
8,110,658
559,132
224,127
209,951
250,870
914,424
927,977
83,274
71,152
21,484
Other Income Or Grants
Cost Of Sales
2,337,884
4,936,574
369,707
149,914
137,385
160,895
563,180
557,793
50,558
45,028
13,716
Gross Profit
1,554,126
3,174,084
189,426
74,213
72,566
89,975
351,245
370,184
32,716
26,125
7,768
Admin Expenses
487,835
1,588,741
188,422
75,229
71,761
93,172
347,945
368,155
30,152
25,278
7,259
Operating Profit
1,066,291
1,585,343
1,004
-1,016
805
-3,197
3,300
2,029
2,564
847
509
Interest Payable
124
42
Interest Receivable
185,534
32,195
155
74
11
180
123
87
17
2
Pre-Tax Profit
1,251,701
1,617,495
1,159
-942
816
-3,017
3,423
2,116
2,581
849
509
Tax
-312,925
-307,324
-220
-155
-684
-423
-542
-195
-122
Profit After Tax
938,776
1,310,171
939
-942
661
-3,017
2,738
1,693
2,039
654
387
Dividends Paid
Retained Profit
938,776
1,310,171
939
-942
661
-3,017
2,738
1,693
2,039
654
387
Employee Costs
531,074
491,352
59,964
53,529
53,433
103,583
350,485
384,000
43,261
43,139
44,589
Number Of Employees
9
9
1
1
1
2
7
8
1
1
1
EBITDA*
1,126,473
1,607,478
15,698
13,260
16,139
12,600
19,097
5,354
5,889
1,311
509
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2023
Jul 2022
Jul 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Tangible Assets
786,352
195,189
14,444
28,710
24,944
40,278
56,075
9,511
12,837
1,857
Intangible Assets
Investments & Other
628,986
150,000
Debtors (Due After 1 year)
Total Fixed Assets
1,415,338
345,189
14,444
28,710
24,944
40,278
56,075
9,511
12,837
1,857
Stock & work in progress
27,480
72,000
83,000
2,510
2,430
2,500
2,110
1,800
2,050
2,100
2,600
Trade Debtors
104,407
130,240
136,803
12,665
3,620
20,335
13,118
11,079
2,951
Group Debtors
512,916
467,024
230,782
Misc Debtors
18,978
78,083
107,630
108,958
4,684
9,326
55,672
Cash
2,433,520
4,987,837
163,322
147,496
522
2,512
69,657
28,706
6,019
698
110
misc current assets
478
total current assets
3,097,301
5,735,184
613,907
270,301
115,530
30,509
81,093
86,178
21,187
13,877
5,661
total assets
4,512,639
6,080,373
628,351
299,011
140,474
70,787
137,168
95,689
34,024
15,734
5,661
Bank overdraft
1,091
1,165
Bank loan
Trade Creditors
1,805,811
4,037,137
4,271
58,548
86,954
66,180
51,360
28,366
14,311
5,273
Group/Directors Accounts
34,951
38,681
511,077
other short term finances
hp & lease commitments
368
4,785
11,156
10,262
10,262
21,768
other current liabilities
304,097
650,603
100,312
211,796
24,561
29,790
30,484
37,644
total current liabilities
2,145,950
4,727,954
620,445
281,500
121,777
40,052
118,432
89,004
28,366
14,311
5,273
loans
hp & lease commitments
7,833
8,793
18,578
Accruals and Deferred Income
other liabilities
provisions
112,580
37,086
2,744
5,455
4,739
7,653
11,215
1,902
2,568
372
total long term liabilities
112,580
37,086
2,744
13,288
13,532
26,231
11,215
1,902
2,568
372
total liabilities
2,258,530
4,765,040
623,189
294,788
135,309
66,283
129,647
90,906
30,934
14,683
5,273
net assets
2,254,109
1,315,333
5,162
4,223
5,165
4,504
7,521
4,783
3,090
1,051
388
total shareholders funds
2,254,109
1,315,333
5,162
4,223
5,165
4,504
7,521
4,783
3,090
1,051
388
Jul 2023
Jul 2022
Jul 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Operating Activities
Operating Profit
1,066,291
1,585,343
1,004
-1,016
805
-3,197
3,300
2,029
2,564
847
509
Depreciation
60,182
22,135
14,694
14,276
15,334
15,797
15,797
3,325
3,325
464
Amortisation
Tax
-312,925
-307,324
-220
-155
-684
-423
-542
-195
-122
Stock
-44,520
-11,000
80,490
80
-70
390
310
-250
-50
-500
2,600
Debtors
-39,046
307,762
247,290
7,717
87,559
15,693
-46,346
42,554
2,039
8,128
2,951
Creditors
-2,231,326
4,032,866
-54,277
-28,406
86,954
-66,180
14,820
22,994
14,055
9,038
5,273
Accruals and Deferred Income
-346,506
550,291
-111,484
187,235
-5,229
-694
-7,160
37,644
Deferred Taxes & Provisions
75,494
34,342
-2,711
716
-2,914
-3,562
9,313
-666
2,196
372
Cash flow from operations
-1,605,224
5,620,891
-480,774
165,008
7,306
-73,919
81,422
22,599
19,609
2,898
109
Investing Activities
capital expenditure
-651,345
-202,880
-428
-18,042
-62,361
1
-14,305
-2,321
Change in Investments
478,986
150,000
cash flow from investments
-1,130,331
-352,880
-428
-18,042
-62,361
1
-14,305
-2,321
Financing Activities
Bank loans
Group/Directors Accounts
-3,730
-472,396
511,077
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
-368
-4,417
-14,204
-66
-9,785
7,072
21,768
other long term liabilities
share issue
9
1
interest
185,410
32,153
155
74
11
180
123
87
17
2
cash flow from financing
181,312
-444,660
497,028
8
-9,774
7,252
21,891
87
17
11
1
cash and cash equivalents
cash
-2,554,317
4,824,515
15,826
146,974
-1,990
-67,145
40,951
22,687
5,321
588
110
overdraft
-74
1,165
change in cash
-2,554,243
4,823,350
15,826
146,974
-1,990
-67,145
40,951
22,687
5,321
588
110
prestige diagnostics u.k. ltd Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for prestige diagnostics u.k. ltd. Get real-time insights into prestige diagnostics u.k. ltd's credit score, group structure and payment trends.
Perform a competitor analysis for prestige diagnostics u.k. ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in BT42 area or any other competitors across 12 key performance metrics.
prestige diagnostics u.k. ltd Ownership
PRESTIGE DIAGNOSTICS U.K. LTD group structure
Prestige Diagnostics U.K. Ltd has no subsidiary companies.
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to prestige diagnostics u.k. ltd.
prestige diagnostics u.k. ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PRESTIGE DIAGNOSTICS U.K. LTD. This can take several minutes, an email will notify you when this has completed.
prestige diagnostics u.k. ltdCompanies House Filings - See Documents
